Investment Thesis
Littelfuse demonstrates fortress-like financial health with excellent liquidity (2.61x current ratio), conservative leverage (0.25x debt/equity), and positive free cash flow, but fundamental operational distress is evident from a catastrophic 171.6% YoY earnings decline despite 8.9% revenue growth. Severely depressed returns on equity (3.0%) and assets (1.9%) indicate structural capital efficiency problems requiring clarification before conviction.
Strengths
- Revenue growth of 8.9% YoY in competitive industrial sector demonstrates market demand
- Exceptional balance sheet with 2.61x current ratio, 1.82x quick ratio, and robust $481.7M cash position
- Conservative capital structure at 0.25x debt/equity with comfortable 10.5x interest coverage ratio
- Positive free cash flow of $66.2M with 10.1% FCF margin provides cushion
Risks
- Severe earnings collapse of 171.6% YoY despite revenue growth indicates operational deterioration or significant one-time charges
- Critically low return on equity (3.0%) and return on assets (1.9%) suggest entrenched capital efficiency problems
- Gross margin of 38.7% may be insufficient to support 3.9B asset base, indicating margin compression
- Earnings decline pattern unresolved - requires visibility into whether charges are temporary or structural
Key Metrics to Watch
- Operating margin trend and gross margin drivers to assess cost inflation/pricing power
- Return on equity recovery trajectory - 3% is unsustainable for mature industrial company
- Explanation and non-recurrence of 171.6% YoY net income decline
- Free cash flow conversion and capital allocation priorities
Financial Metrics
Revenue
657.0M
Net Income
75.1M
EPS (Diluted)
$2.96
Free Cash Flow
66.2M
Total Assets
3.9B
Cash
481.7M
Profitability Ratios
Gross Margin
38.7%
Operating Margin
15.4%
Net Margin
11.4%
ROE
3.0%
ROA
1.9%
FCF Margin
10.1%
Balance Sheet & Liquidity
Current Ratio
2.61x
Quick Ratio
1.82x
Debt/Equity
0.25x
Debt/Assets
34.8%
Interest Coverage
10.53x
Long-term Debt
631.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-08T10:58:11.474168 |
Data as of: 2026-03-28 |
Powered by Claude AI